Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2000
06/02/2000CA2351719A1 Pharmaceutical compositions containing olanzapine-n-oxide
06/02/2000CA2351718A1 Desmethylolanzapine compositions and methods
06/02/2000CA2351691A1 Oral creatine supplementation for treating or preventing muscle disuse syndrome
06/02/2000CA2351679A1 Prostaglandin conjugates for treating or preventing bone disease
06/02/2000CA2351664A1 2-acylamino-2-deoxy-glucono-1,5-lactones, method for obtaining same, compositions comprising them and uses
06/02/2000CA2351631A1 Piperidine quaternary salts-ccr-3 receptor antagonists
06/02/2000CA2351526A1 Indole derivatives and their use as serotonin receptor ligands
06/02/2000CA2351497A1 Cycloalkyl-substituted aminomethylpyrrolidine derivative
06/02/2000CA2351446A1 Benzoxazole derivatives and medicaments comprising said derivatives as active ingredient
06/02/2000CA2351365A1 Potassium channel interactors and uses therefor
06/02/2000CA2351354A1 Hexapeptide with the stabilized disulfide bond and derivatives thereof regulating metabolism, proliferation, differentiation and apoptosis
06/02/2000CA2351348A1 Substituted benzo[de]isoquinoline-1,3-diones
06/02/2000CA2351347A1 Dosage formulations for acetylcholinesterase inhibitors
06/02/2000CA2351061A1 Benzyllactobionamides as inhibitors of smooth muscle cell proliferation
06/02/2000CA2350969A1 Compounds having cytokine inhibitory activity
06/02/2000CA2350903A1 Pyrrolidine derivatives-ccr-3 receptor antagonists
06/02/2000CA2350759A1 Benzylmaltotriosides as inhibitors of smooth muscle cell proliferation
06/02/2000CA2350758A1 Benzylglycosylamides as inhibitors of smooth muscle cell proliferation
06/02/2000CA2350755A1 Benzylglycosylamides as inhibitors of smooth muscle cell proliferation
06/02/2000CA2350753A1 Benzylmaltosides as inhibitors of smooth muscle cell proliferation
06/02/2000CA2350599A1 Method of inhibiting angiogenesis
06/02/2000CA2350594A1 Coating useful as a dispenser of an active ingredient on dressings and bandages
06/02/2000CA2350405A1 Method of using pon-1 to decrease atheroma formation
06/02/2000CA2350395A1 Nucleotide and protein sequences of nogo genes and methods based thereon
06/02/2000CA2350189A1 Recombinant methods and materials for producing epothilone and epothilone derivatives
06/02/2000CA2350066A1 Acetal benzylmaltosides as inhibitors of smooth muscle cell proliferation
06/02/2000CA2349721A1 N-¬4-(3-chloro-4-fluoro-phenylamino)-7-(3-morpholin-4-yl-propoxy)-quinazolin-6-yl|-acrylamide, an irreversible inhibitor of tyrosine kinases
06/02/2000CA2349555A1 Composition and use of rar antagonists for promoting chondrogenesis
06/02/2000CA2349229A1 Prevention and treatment of amyloid-associated disorders
06/02/2000CA2348876A1 Compositions comprising cefuroxime axetil
06/02/2000CA2347940A1 Use of core 2 glcnac transferase inhibitors in treating inflammation
06/02/2000CA2332882A1 A process for producing an iron-dextran compound
06/02/2000CA2291880A1 Novel derivatives of 2-(2-oxo-ethylidene)-imidazolidin-4-one, and compositions and methods for inhibiting abnormal cell growth comprising said derivatives
06/02/2000CA2291453A1 Dna-constructs of blood clotting factors and p-selectin
05/2000
05/31/2000EP1004675A2 Methods of screening for nucleoside analogs that are incorporated by HIV reverse transcriptase and cause incorrect base pairing
05/31/2000EP1004670A2 Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents
05/31/2000EP1004654A2 Adjuvants and methods for raising intracellular calcium ion concentration
05/31/2000EP1004594A1 Phytosterol and/or phytostanol derivatives
05/31/2000EP1004593A2 Backbone modified oligonucleotide analogues
05/31/2000EP1004592A1 Derivatives of erythromycin, their process of preparation and their application as medicaments
05/31/2000EP1004586A2 Method for producing 2-methylspiro(1,3-Oxathiolane-5,3')quinuclidine
05/31/2000EP1004584A2 Pyranoquinoline derivatives as inhibitors of cell proliferation
05/31/2000EP1004582A2 Pyridazino quinoline compounds
05/31/2000EP1004581A2 Process for the preparation of thalidomide
05/31/2000EP1004580A2 Imides as inhibitors of TNF alpha
05/31/2000EP1004578A2 5-oxo-pyrrolidine-2-carboxylic acid hydroxamide derivatives
05/31/2000EP1004572A2 Amines as inhibitors of TNF alpha
05/31/2000EP1004320A1 Use of magnesium (Mg2+) for the enhancement of gene delivery in gene therapy
05/31/2000EP1004319A1 Remedies for solid tumor containing wilms' tumor gene (wt1) expression inhibitors
05/31/2000EP1004318A2 Cyclodextrin composition
05/31/2000EP1004317A1 Remedies for diseases associated with bone resorption
05/31/2000EP1004316A1 Remedies for complications of diabetes
05/31/2000EP1004312A1 Method for treating multiple sclerosis
05/31/2000EP1004309A1 Israpafant-containing water-base preparations
05/31/2000EP1004308A1 Preventives or remedies for drug-induced renal disturbance
05/31/2000EP1004307A2 Ophthalmic composition
05/31/2000EP1004306A2 Estrogen agonists/antagonists
05/31/2000EP1004305A1 Stabilized compositions containing benzimidazole-type compounds
05/31/2000EP1004304A1 Composition containing ascorbic acid
05/31/2000EP1004302A2 Immunomodulator
05/31/2000EP1004301A1 Protecting and survival promoting agent for central nervous cell
05/31/2000EP1004300A1 Anion regulator for ruminants
05/31/2000EP1004299A1 Antigen inducers, vaccine precursors, vaccines, antibodies, neutralizing antibodies, antitoxins, idiotypic antibodies, and anti-idiotypic antibodies induced by the idiotypic antibodies
05/31/2000EP1004298A2 Controlled release tablet of bupropion hydrochloride
05/31/2000EP1004296A1 Powder containing fat-soluble drug
05/31/2000EP1004294A1 Pharmaceutical composition comprising a nitric oxide (NO) donating organic compound
05/31/2000EP1004022A1 Methods and compositions for overcoming resistance to biologic and chemotherapy
05/31/2000EP1003916A1 Antisense oligonucleotide compositions and methods for the modulation of jnk proteins
05/31/2000EP1003903A1 Process for preparing enantiomerically enriched n-derivatised lactams
05/31/2000EP1003898A1 Integrin-targeting vectors having transfection activity
05/31/2000EP1003897A1 Complexes for transporting nucleic acid into eukaryotic higher-cells
05/31/2000EP1003878A2 Hiv-1 group o antigens and uses thereof
05/31/2000EP1003850A1 Inhibitors of dna immunostimulatory sequence activity
05/31/2000EP1003846A1 Protease inhibitors
05/31/2000EP1003783A2 Lipoprotein-regulating medicaments
05/31/2000EP1003781A1 Interleukin-18 binding proteins, their preparation and use
05/31/2000EP1003777A1 PGC-1, A NOVEL BROWN FAT PPAR$g(g) COACTIVATOR
05/31/2000EP1003776A1 Gene and amino acid sequences for novel transcription factor
05/31/2000EP1003773A1 Ctl epitopes from ebv
05/31/2000EP1003769A1 Compositions that specifically bind to colorectal cancer cells and methods of using the same
05/31/2000EP1003764A1 Improved process for antiparasitic agent
05/31/2000EP1003763A1 83 human secreted proteins
05/31/2000EP1003762A2 Base analogues
05/31/2000EP1003761A2 A process for the purification of acarbose
05/31/2000EP1003752A1 3-substituted 3,4,5,7-tetrahydro-pyrrolo3',4':4,5 thieno2,3-dpyrimidine derivatives, their preparation and use as 5ht antagonists
05/31/2000EP1003751A1 Hydroxamic acid substituted fused heterocyclic metalloproteinase inhibitors
05/31/2000EP1003750A1 Methods of preparing and purifying 9-nitro-20-camptothecin
05/31/2000EP1003749A1 8-SUBSTITUTED-9H-1,3-DIOXOLO/4,5-h/2,3/BENZODIAZEPINE DERIVATES, AS AMPA/KAINATERECEPTOR INHIBITORS
05/31/2000EP1003748A2 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
05/31/2000EP1003747A1 Carbapenems with naphthosultam derivative linked via methylene
05/31/2000EP1003746A1 Purine inhibitor of protein kinases, g proteins and polymerases
05/31/2000EP1003745A1 Naphthyridinones for inhibiting protein tyrosine kinase and cell cycle kinase mediated cellular proliferation
05/31/2000EP1003744A1 4-AMINOPYRROLE(3,2-d) PYRIMIDINES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS
05/31/2000EP1003743A1 3,3-disubstituted piperidines as modulators of chemokine receptor activity
05/31/2000EP1003740A2 Pyrrolidine-3-carboxylic acid derivatives and their use as endothelin antagoists
05/31/2000EP1003739A2 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-1h-indole derivatives
05/31/2000EP1003738A1 Bicyclic compounds as ligands for 5-ht1 receptors
05/31/2000EP1003737A1 Phenyl urea and phenyl thiourea derivatives as hfgan72 antagonists
05/31/2000EP1003735A1 Quinolizine carboxylic acid derivatives
05/31/2000EP1003734A2 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONIST
1 ... 6308 6309 6310 6311 6312 6313 6314 6315 6316 6317 6318 6319 6320 6321 6322 6323 6324 6325 6326 6327 6328 ... 7860